Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
3
×
san francisco blog main
boston blog main
boston top stories
boulder/denver blog main
detroit blog main
indiana blog main
new york blog main
raleigh-durham blog main
san diego blog main
san francisco top stories
seattle blog main
texas blog main
wisconsin blog main
38 studios
accelerator
aidan petrie
aimmune therapeutics
alopecia areata
amarin
arena pharmaceuticals
avapritinib
bankruptcy
bio
blueprint medicines
boehringer ingelheim
boston
boston red sox
boulder/denver top stories
cadent therapeutics
cancer
cancer immunotherapy
celgene
centers for disease control and prevention
centrexion therapeutics
city
civic
What
little
3
×
life
science
arena’s
benefit
better
bio
boston’s
bounty
capital
cig
city
comeback
companies
corner
deals
delivered
editing
expressing
fights
founder
gene
going
humans
ipo
island
isn't
jobs
landmark
medicine
moderna’s
morning
nasdaq
number
phase
providence
punched
reported
reports
respect
Language
Current search:
little
×
" national top stories "
×
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect